Financhill
Buy
65

ELMD Quote, Financials, Valuation and Earnings

Last price:
$33.34
Seasonality move :
17.67%
Day range:
$28.00 - $29.66
52-week range:
$10.05 - $35.56
Dividend yield:
0%
P/E ratio:
40.56x
P/S ratio:
4.56x
P/B ratio:
5.95x
Volume:
180.9K
Avg. volume:
97.4K
1-year change:
181.31%
Market cap:
$247M
Revenue:
$54.7M
EPS (TTM):
$0.72

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ELMD
Electromed
$15.3M -- 11.77% -- --
AXGN
Axogen
$48.6M $0.03 10.54% -76% $20.00
CUTR
Cutera
$35.4M -$0.98 -28.73% -56.83% --
IRIX
IRIDEX
$12.8M -$0.12 -2.72% -18.18% --
MYO
Myomo
$9.9M -$0.02 108.09% -66.67% --
STXS
Stereotaxis
$6.4M -$0.07 40.75% -8.33% $4.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ELMD
Electromed
$29.20 -- $247M 40.56x $0.00 0% 4.56x
AXGN
Axogen
$17.52 $20.00 $771M -- $0.00 0% 4.21x
CUTR
Cutera
$0.41 -- $8.3M -- $0.00 0% 0.05x
IRIX
IRIDEX
$1.58 -- $26.3M -- $0.00 0% 0.53x
MYO
Myomo
$5.97 -- $201.2M -- $0.00 0% 8.72x
STXS
Stereotaxis
$2.35 $4.50 $199.1M -- $0.00 0% 7.87x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ELMD
Electromed
-- 2.128 -- 4.99x
AXGN
Axogen
32.23% 0.809 7.66% 2.13x
CUTR
Cutera
250.93% -4.044 2641.48% 1.68x
IRIX
IRIDEX
51.25% 0.946 9.47% 0.73x
MYO
Myomo
-- 1.004 -- 1.48x
STXS
Stereotaxis
-- 2.343 -- 0.90x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ELMD
Electromed
$11.5M $1.9M 15.62% 15.62% 13.21% $2.3M
AXGN
Axogen
$36.4M -$316K -9.99% -14.85% 0.07% $2.8M
CUTR
Cutera
$1.8M -$36.2M -62.63% -- -109.09% -$24.9M
IRIX
IRIDEX
$4.3M -$1.9M -146.36% -157.91% -16.15% -$3.1M
MYO
Myomo
$6.9M -$957.6K -84.04% -84.04% -10.4% -$1.8M
STXS
Stereotaxis
$4.1M -$6.3M -108.68% -108.68% -69% -$4.3M

Electromed vs. Competitors

  • Which has Higher Returns ELMD or AXGN?

    Axogen has a net margin of 10.05% compared to Electromed's net margin of -3.82%. Electromed's return on equity of 15.62% beat Axogen's return on equity of -14.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    78.34% $0.16 $41.5M
    AXGN
    Axogen
    74.91% -$0.04 $146.7M
  • What do Analysts Say About ELMD or AXGN?

    Electromed has a consensus price target of --, signalling upside risk potential of 13.01%. On the other hand Axogen has an analysts' consensus of $20.00 which suggests that it could grow by 14.16%. Given that Axogen has higher upside potential than Electromed, analysts believe Axogen is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    0 0 0
    AXGN
    Axogen
    4 0 0
  • Is ELMD or AXGN More Risky?

    Electromed has a beta of 0.334, which suggesting that the stock is 66.566% less volatile than S&P 500. In comparison Axogen has a beta of 0.996, suggesting its less volatile than the S&P 500 by 0.442%.

  • Which is a Better Dividend Stock ELMD or AXGN?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Axogen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or AXGN?

    Electromed quarterly revenues are $14.7M, which are smaller than Axogen quarterly revenues of $48.6M. Electromed's net income of $1.5M is higher than Axogen's net income of -$1.9M. Notably, Electromed's price-to-earnings ratio is 40.56x while Axogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 4.56x versus 4.21x for Axogen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    4.56x 40.56x $14.7M $1.5M
    AXGN
    Axogen
    4.21x -- $48.6M -$1.9M
  • Which has Higher Returns ELMD or CUTR?

    Cutera has a net margin of 10.05% compared to Electromed's net margin of -120.06%. Electromed's return on equity of 15.62% beat Cutera's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    78.34% $0.16 $41.5M
    CUTR
    Cutera
    5.58% -$1.94 $167.5M
  • What do Analysts Say About ELMD or CUTR?

    Electromed has a consensus price target of --, signalling upside risk potential of 13.01%. On the other hand Cutera has an analysts' consensus of -- which suggests that it could grow by 384.03%. Given that Cutera has higher upside potential than Electromed, analysts believe Cutera is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    0 0 0
    CUTR
    Cutera
    2 3 0
  • Is ELMD or CUTR More Risky?

    Electromed has a beta of 0.334, which suggesting that the stock is 66.566% less volatile than S&P 500. In comparison Cutera has a beta of 1.320, suggesting its more volatile than the S&P 500 by 31.994%.

  • Which is a Better Dividend Stock ELMD or CUTR?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cutera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Cutera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or CUTR?

    Electromed quarterly revenues are $14.7M, which are smaller than Cutera quarterly revenues of $32.5M. Electromed's net income of $1.5M is higher than Cutera's net income of -$39M. Notably, Electromed's price-to-earnings ratio is 40.56x while Cutera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 4.56x versus 0.05x for Cutera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    4.56x 40.56x $14.7M $1.5M
    CUTR
    Cutera
    0.05x -- $32.5M -$39M
  • Which has Higher Returns ELMD or IRIX?

    IRIDEX has a net margin of 10.05% compared to Electromed's net margin of -16.69%. Electromed's return on equity of 15.62% beat IRIDEX's return on equity of -157.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    78.34% $0.16 $41.5M
    IRIX
    IRIDEX
    37.33% -$0.12 $5.4M
  • What do Analysts Say About ELMD or IRIX?

    Electromed has a consensus price target of --, signalling upside risk potential of 13.01%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 26.58%. Given that IRIDEX has higher upside potential than Electromed, analysts believe IRIDEX is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    0 0 0
    IRIX
    IRIDEX
    0 0 0
  • Is ELMD or IRIX More Risky?

    Electromed has a beta of 0.334, which suggesting that the stock is 66.566% less volatile than S&P 500. In comparison IRIDEX has a beta of 0.836, suggesting its less volatile than the S&P 500 by 16.432%.

  • Which is a Better Dividend Stock ELMD or IRIX?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or IRIX?

    Electromed quarterly revenues are $14.7M, which are larger than IRIDEX quarterly revenues of $11.6M. Electromed's net income of $1.5M is higher than IRIDEX's net income of -$1.9M. Notably, Electromed's price-to-earnings ratio is 40.56x while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 4.56x versus 0.53x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    4.56x 40.56x $14.7M $1.5M
    IRIX
    IRIDEX
    0.53x -- $11.6M -$1.9M
  • Which has Higher Returns ELMD or MYO?

    Myomo has a net margin of 10.05% compared to Electromed's net margin of -10.5%. Electromed's return on equity of 15.62% beat Myomo's return on equity of -84.04%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    78.34% $0.16 $41.5M
    MYO
    Myomo
    75.43% -$0.03 $9.3M
  • What do Analysts Say About ELMD or MYO?

    Electromed has a consensus price target of --, signalling upside risk potential of 13.01%. On the other hand Myomo has an analysts' consensus of -- which suggests that it could grow by 28.42%. Given that Myomo has higher upside potential than Electromed, analysts believe Myomo is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    0 0 0
    MYO
    Myomo
    0 0 0
  • Is ELMD or MYO More Risky?

    Electromed has a beta of 0.334, which suggesting that the stock is 66.566% less volatile than S&P 500. In comparison Myomo has a beta of 1.683, suggesting its more volatile than the S&P 500 by 68.262%.

  • Which is a Better Dividend Stock ELMD or MYO?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or MYO?

    Electromed quarterly revenues are $14.7M, which are larger than Myomo quarterly revenues of $9.2M. Electromed's net income of $1.5M is higher than Myomo's net income of -$966.4K. Notably, Electromed's price-to-earnings ratio is 40.56x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 4.56x versus 8.72x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    4.56x 40.56x $14.7M $1.5M
    MYO
    Myomo
    8.72x -- $9.2M -$966.4K
  • Which has Higher Returns ELMD or STXS?

    Stereotaxis has a net margin of 10.05% compared to Electromed's net margin of -67.31%. Electromed's return on equity of 15.62% beat Stereotaxis's return on equity of -108.68%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    78.34% $0.16 $41.5M
    STXS
    Stereotaxis
    44.57% -$0.08 $16.2M
  • What do Analysts Say About ELMD or STXS?

    Electromed has a consensus price target of --, signalling upside risk potential of 13.01%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 91.49%. Given that Stereotaxis has higher upside potential than Electromed, analysts believe Stereotaxis is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    0 0 0
    STXS
    Stereotaxis
    2 0 0
  • Is ELMD or STXS More Risky?

    Electromed has a beta of 0.334, which suggesting that the stock is 66.566% less volatile than S&P 500. In comparison Stereotaxis has a beta of 1.537, suggesting its more volatile than the S&P 500 by 53.666%.

  • Which is a Better Dividend Stock ELMD or STXS?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or STXS?

    Electromed quarterly revenues are $14.7M, which are larger than Stereotaxis quarterly revenues of $9.2M. Electromed's net income of $1.5M is higher than Stereotaxis's net income of -$6.2M. Notably, Electromed's price-to-earnings ratio is 40.56x while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 4.56x versus 7.87x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    4.56x 40.56x $14.7M $1.5M
    STXS
    Stereotaxis
    7.87x -- $9.2M -$6.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock